Heron Therapeutics (HRTX) Earnings Date, Estimates & Call Transcripts $2.04 -0.27 (-11.47%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Heron Therapeutics Earnings Summary Upcoming Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Feb. 27) -$0.03 Actual EPS (Feb. 27) $0.02 Beat By $0.05 Actual Revenue (Feb. 27) $40.78MHeron Therapeutics announced Q4 2024 earnings on February 27, 2025, reporting an EPS of $0.02, which topped analysts' consensus estimates of -$0.03 by $0.05. Quarterly revenue was reported to be $40.78 million, above analyst estimates of $37.37 million. With a trailing EPS of -$0.09, Heron Therapeutics' earnings are expected to grow next year, from ($0.13) to ($0.05) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Annual Report (10-K)HRTX Upcoming EarningsHeron Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Heron Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heron Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HRTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Heron Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.01-$0.01-$0.01Q2 20251$0.00$0.00$0.00Q3 20251$0.00$0.00$0.00Q4 20251$0.01$0.01$0.01 Heron Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/27/2025Q4 2024-$0.03$0.02+$0.05$0.02$37.37M$40.78M11/12/2024Q3 2024-$0.03-$0.03--$0.03$36.40M$32.81M8/6/2024Q2 2024-$0.04-$0.06 -$0.02-$0.06$35.35M$36.02M5/7/2024Q1 2024-$0.08-$0.02+$0.06-$0.02$32.50M$34.67M3/12/2024Q4 2023-$0.15-$0.07+$0.08-$0.07$30.98M$34.23M11/14/2023Q3 2023-$0.31-$0.17+$0.14-$0.17$31.63M$31.43M8/14/2023Q2 2023-$0.23-$0.35 -$0.12-$0.35$31.75M$31.76M5/11/2023Q1 2023-$0.17-$0.27 -$0.10-$0.27$28.30M$29.62M Heron Therapeutics Earnings - Frequently Asked Questions When is Heron Therapeutics's earnings date? Heron Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on HRTX's earnings history. What guidance has Heron Therapeutics issued on next quarter's earnings? Heron Therapeutics updated its FY 2025 earnings guidance on Thursday, February, 27th. The company issued revenue guidance of $153.0 million-$163.0 million, compared to the consensus revenue estimate of $160.6 million. Did Heron Therapeutics beat their earnings estimates last quarter? In the previous quarter, Heron Therapeutics (NASDAQ:HRTX) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.05. Learn more on analysts' earnings estimate vs. HRTX's actual earnings. How can I listen to Heron Therapeutics's earnings conference call? The conference call for Heron Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Heron Therapeutics's conference call transcript? The conference call transcript for Heron Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Heron Therapeutics generate each year? Heron Therapeutics (NASDAQ:HRTX) has a recorded annual revenue of $144.29 million. How much profit does Heron Therapeutics generate each year? Heron Therapeutics (NASDAQ:HRTX) has a recorded net income of -$110.56 million. HRTX has generated -$0.09 earnings per share over the last four quarters. What is Heron Therapeutics's EPS forecast for next year? Heron Therapeutics's earnings are expected to grow from ($0.13) per share to ($0.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies ARS Pharmaceuticals Earnings Results Structure Therapeutics Earnings Results Ocular Therapeutix Earnings Results Dyne Therapeutics Earnings Results Ardelyx Earnings Results Calliditas Therapeutics AB (publ) Earnings Results Iovance Biotherapeutics Earnings Results Amphastar Pharmaceuticals Earnings Results Syndax Pharmaceuticals Earnings Results Adaptive Biotechnologies Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:HRTX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRTX Stock Free HRTX Stock Alerts